Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Biol Macromol ; 268(Pt 2): 131671, 2024 May.
Article in English | MEDLINE | ID: mdl-38641272

ABSTRACT

In this study, N-Methyl-N-nitrosourea (MNU) was intraperitoneally injected to construct a mouse retinitis pigmentosa (RP) model to evaluate the protective effect of chitosan and ß-carotene on RP. The results demonstrated that chitosan synergized with ß-carotene significantly reduced retinal histopathological structural damage in RP mice. The co-treatment group of ß-carotene and chitosan restored the retinal thickness and outer nuclear layer thickness better than the group treated with the two alone, and the thickness reached the normal level. The content of ß-carotene and retinoids in the liver of chitosan and ß-carotene co-treated group increased by 46.75 % and 20.69 %, respectively, compared to the ß-carotene group. Chitosan and ß-carotene supplement suppressed the expressions of Bax, Calpain2, Caspase3, NF-κB, TNF-α, IL-6, and IL-1ß, and promoted the up-regulation of Bcl2. Chitosan and ß-carotene interventions remarkably contributed to the content of SCFAs and enhanced the abundance of Ruminococcaceae, Rikenellaceae, Odoribacteraceae and Helicobacteraceae. Correlation analysis demonstrated a strong association between gut microbiota and improvement in retinitis pigmentosa. This study will provide a reference for the study of the gut-eye axis.


Subject(s)
Chitosan , Methylnitrosourea , Retinitis Pigmentosa , beta Carotene , Animals , beta Carotene/pharmacology , Chitosan/pharmacology , Chitosan/chemistry , Retinitis Pigmentosa/drug therapy , Retinitis Pigmentosa/metabolism , Retinitis Pigmentosa/pathology , Mice , Drug Synergism , Retina/drug effects , Retina/metabolism , Retina/pathology , Disease Models, Animal , Gastrointestinal Microbiome/drug effects , Male , Retinoids/pharmacology , Liver/drug effects , Liver/pathology , Liver/metabolism
2.
Food Res Int ; 174(Pt 1): 113592, 2023 12.
Article in English | MEDLINE | ID: mdl-37986456

ABSTRACT

This study aimed to evaluate the effects of six polysaccharides on the utilization of ß-carotene from the perspective of gut microbiota using both in vitro simulated anaerobic fermentation systems and in vivo animal experiments. In the in vitro experiments, the addition of arabinoxylan, arabinogalactan, mannan, inulin, chitosan, and glucan led to a 31.07-79.12% decrease in ß-carotene retention and a significant increase in retinol content (0.21-0.99-fold) compared to ß-carotene alone. Among them, the addition of chitosan produced the highest level of retinol. In the in vivo experiments, mice treated with the six polysaccharides exhibited a significant increase (2.51-5.78-fold) in serum ß-carotene content compared to the group treated with ß-carotene alone. The accumulation of retinoids in the serum, liver, and small intestine increased by 13.56-21.61%, 12.64-56.27%, and 7.9%-71.69%, respectively. The expression of ß-carotene cleavage enzymes was increased in the liver. Genetic analysis of small intestinal tissue revealed no significant enhancement in the expression of genes related to ß-carotene metabolism. In the gut microbiota environment, the addition of polysaccharides generated more SCFAs and altered the structure and composition of the gut microbiota. The correlation analysis revealed a strong association between gut microbes (Ruminococcaceae and Odoribacteraceae) and ß-carotene metabolism and absorption. Collectively, our findings suggest that the addition of polysaccharides may improve ß-carotene utilization by modulating the gut microbiota.


Subject(s)
Chitosan , Gastrointestinal Microbiome , Mice , Animals , beta Carotene/metabolism , Vitamin A , Polysaccharides/pharmacology
3.
J Agric Food Chem ; 70(42): 13592-13601, 2022 Oct 26.
Article in English | MEDLINE | ID: mdl-36214842

ABSTRACT

Recent studies indicated a strong relationship between carotenoids and gut microflora. However, their structure-activity relationship remains unclear. This study evaluated the interaction between four typical carotenoids (ß-carotene, lutein, lycopene, and astaxanthin) and gut microflora using an in vitro fermentation model. After 24 h of fermentation, the retention rates of the four carotenoids were 1.40, 1.38, 1.46, and 5.63 times lower than those of their without gut microflora control groups, respectively. All four carotenoid treated groups significantly increased total short-chain fatty acids (SCFAs) production. All carotenoid supplements significantly promoted the abundance of Roseburia and Parasutterella and inhibited the abundance of Collinsella, while ß-carotene, lutein, lycopene, and astaxanthin significantly promoted the abundance of Ruminococcus, Sutterella, Subdoligranulum, and Megamonas, respectively. Furthermore, xanthophylls have a more significant impact on gut microflora than carotenes. This study provides a new way to understand how carotenoids work in the human body with the existing gut microflora.


Subject(s)
Carotenoids , Gastrointestinal Microbiome , Humans , Carotenoids/metabolism , Lutein/pharmacology , Lutein/metabolism , beta Carotene , Lycopene , Fermentation , Xanthophylls/pharmacology , Zeaxanthins
SELECTION OF CITATIONS
SEARCH DETAIL